|
End-of-day quote
Shanghai S.E.
21/08/2026
|
5-day change | 1st Jan Change | ||
| 6.870 CNY | -3.92% |
|
-1.43% | +5.86% |
| Market Cap | 4.75B 707M 606M 567M 519M 974M 67.66B 987M 6.7B 2.61B 33.99B 2.66B 2.6B 112B | P/E 2024 |
18.1x | P/E 2025 | 14.2x |
|---|---|---|---|---|---|
| Enterprise Value | 3.97B 591M 506M 473M 433M 813M 56.5B 824M 5.59B 2.18B 28.38B 2.22B 2.17B 93.88B | EV / Sales 2024 |
1.45x | EV / Sales 2025 | 1.65x |
| Free-Float |
79.74% | Yield 2024 |
4.93% | Yield 2025 | 5.39% |
| 1 day | -3.92% | ||
| 1 week | -1.43% | ||
| Current month | +6.18% | ||
| 1 month | +4.25% | ||
| 3 months | +6.51% | ||
| 6 months | +3.78% | ||
| Current year | +5.86% |
| 1 week | 6.84 |  | 7.25 |
| 1 month | 6.33 | | 7.45 |
| Current year | 5.6 | | 7.45 |
| 1 year | 5.6 | | 7.45 |
| 3 years | 4.94 | | 9 |
| 5 years | 4.94 | | 11.9 |
| 10 years | 4.5 | | 11.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei Ren
CEO | Chief Executive Officer | 42 | 22/04/2019 |
Zhe Feng Zuo
DFI | Director of Finance/CFO | 54 | 16/05/2017 |
Peng Bo Ren
PRN | Corporate Officer/Principal | 53 | 10/03/2007 |
| Director | Title | Age | Since |
|---|---|---|---|
Wu Xian Ren
CHM | Chairman | 66 | 25/05/2005 |
Peng Bo Ren
BRD | Director/Board Member | 53 | 14/05/2014 |
Wei Ren
BRD | Director/Board Member | 42 | 22/04/2019 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.92% | -1.43% | -6.02% | -7.66% | 707M | |
| +0.82% | +1.95% | +15.81% | +71.57% | 47.71B | |
| +0.12% | +1.62% | +52.24% | +123.18% | 40.3B | |
| -0.63% | -0.57% | -11.10% | +16.62% | 12.09B | |
| -1.43% | -2.40% | +7.93% | +72.32% | 11.68B | |
| +0.19% | +0.58% | +30.98% | +158.71% | 9.19B | |
| +2.56% | +1.77% | +24.93% | +44.99% | 7.57B | |
| -0.16% | +1.47% | +46.74% | -11.64% | 7.24B | |
| +2.10% | +1.63% | +21.01% | +215.96% | 6.84B | |
| -5.36% | -6.36% | -38.04% | +22.49% | 5.42B | |
| Average | -0.54% | -1.41% | +14.45% | +70.65% | 14.87B | |
| Weighted average by Cap. | +0.17% | -0.59% | +23.96% | +85.60% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.69B 400M 342M 320M 293M 550M 38.23B 557M 3.78B 1.48B 19.2B 1.5B 1.47B 63.52B | 2.24B 333M 285M 267M 244M 459M 31.88B 465M 3.16B 1.23B 16.02B 1.25B 1.22B 52.97B |
| Net income | 243M 36.1M 30.92M 28.94M 26.49M 49.71M 3.45B 50.37M 342M 133M 1.74B 136M 133M 5.74B | 320M 47.6M 40.78M 38.15M 34.93M 65.55M 4.55B 66.41M 451M 176M 2.29B 179M 175M 7.57B |
| Net Debt | -483M -71.83M -61.53M -57.57M -52.7M -98.91M -6.87B -100M -680M -265M -3.45B -270M -264M -11.42B | -784M -117M -99.95M -93.52M -85.6M -161M -11.16B -163M -1.1B -431M -5.61B -438M -429M -18.55B |
Employees
3,415
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/08/26 | CN¥6.870 | -3.92% | 30,607,954 |
| 20/08/26 | CN¥7.150 | +2.29% | 32,805,500 |
| 19/08/26 | CN¥6.990 | -1.41% | 30,889,027 |
| 18/08/26 | CN¥7.090 | -0.98% | 25,905,100 |
| 17/08/26 | CN¥7.160 | +2.73% | 51,017,280 |
- Stock Market
- Stocks
- 600351 Stock
Select your edition
All financial news and data tailored to specific country editions
